Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Atlantic's 2-5A improves efficacy of antisense compounds

Oct. 24, 1997

CombiChem/Athena initiate CNS drug discovery collaboration

Oct. 21, 1997

Aurora Biosciences licenses fluorescent technology from the University of California

Oct. 21, 1997

PharmaPrint and AHP to collaborate on herbal products

Oct. 20, 1997

Promising preclinical data for Inex's gene delivery system

Oct. 16, 1997

Genetronics evaluates its electroporation therapy in phase II

Oct. 16, 1997

Cell Genesys receives notice of patent claims for retroviral gene therapy vectors

Oct. 15, 1997

Cubist and Novalon extend collaboration

Oct. 14, 1997

MorphoGen receives notice of allowance for U.S. patent covering PPMSCs

Oct. 14, 1997

Alkermes issued two U.S. patents for drug delivery system

Oct. 14, 1997

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...